1. Home
  2. LYRA vs BPT Comparison

LYRA vs BPT Comparison

Compare LYRA & BPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • BPT
  • Stock Information
  • Founded
  • LYRA 2005
  • BPT 1989
  • Country
  • LYRA United States
  • BPT United States
  • Employees
  • LYRA N/A
  • BPT N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • BPT Integrated oil Companies
  • Sector
  • LYRA Health Care
  • BPT Energy
  • Exchange
  • LYRA Nasdaq
  • BPT Nasdaq
  • Market Cap
  • LYRA 11.8M
  • BPT 11.7M
  • IPO Year
  • LYRA 2020
  • BPT N/A
  • Fundamental
  • Price
  • LYRA $0.12
  • BPT $0.56
  • Analyst Decision
  • LYRA Hold
  • BPT
  • Analyst Count
  • LYRA 4
  • BPT 0
  • Target Price
  • LYRA $1.25
  • BPT N/A
  • AVG Volume (30 Days)
  • LYRA 828.8K
  • BPT 133.6K
  • Earning Date
  • LYRA 03-13-2025
  • BPT 05-08-2025
  • Dividend Yield
  • LYRA N/A
  • BPT N/A
  • EPS Growth
  • LYRA N/A
  • BPT N/A
  • EPS
  • LYRA N/A
  • BPT N/A
  • Revenue
  • LYRA $1,534,000.00
  • BPT $236,000.00
  • Revenue This Year
  • LYRA N/A
  • BPT N/A
  • Revenue Next Year
  • LYRA $519.89
  • BPT N/A
  • P/E Ratio
  • LYRA N/A
  • BPT N/A
  • Revenue Growth
  • LYRA N/A
  • BPT N/A
  • 52 Week Low
  • LYRA $0.12
  • BPT $0.40
  • 52 Week High
  • LYRA $6.29
  • BPT $3.20
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 23.27
  • BPT 48.30
  • Support Level
  • LYRA $0.14
  • BPT $0.55
  • Resistance Level
  • LYRA $0.20
  • BPT $0.60
  • Average True Range (ATR)
  • LYRA 0.01
  • BPT 0.04
  • MACD
  • LYRA -0.00
  • BPT -0.00
  • Stochastic Oscillator
  • LYRA 1.05
  • BPT 29.64

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About BPT BP Prudhoe Bay Royalty Trust

BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.

Share on Social Networks: